Adding Interventional DED Treatment to Your Practice - Takeaways - MDSpire

Adding Interventional DED Treatment to Your Practice

Interventional treatment for DED before refractive surgery biometry allows practices to offer options like advanced-technology intraocular lenses to more patients.

  • By

  • Neel R. Desai, MD

  • January 1, 2026

  • 14 min

Share

  • 1

    Interventional treatments for dry eye disease (DED) enhance patient care and reduce staff workload in ophthalmology practices.

  • 2

    Adopting an interventional approach allows for team-based care, improving efficiency and patient access to effective treatments.

  • 3

    Lacrimal occlusion with hyaluronic acid gel is a first-line therapy for DED, providing immediate symptomatic relief and improving compliance.

  • 4

    Thermal-activated restorative gland expression therapy (TARGET) effectively treats meibomian gland dysfunction and evaporative disease.

  • 5

    Interventional treatments like TARGET and Lacrifill are supported by data showing better outcomes compared to traditional therapies.

Original Source(s)

Adding Interventional DED Treatment to Your Practice

  • by Neel R. Desai, MD

  • January 1, 2026

Related Content

Dry Eye Dx and Tx: <br>Tailoring the Tear Reservoir</br>

Transcriptomic Analysis of Lacrimal Glands in a Sjogren’s Disease Animal Model Reveals Key Molecular Factors and Altered Biological Processes Associated with Glandular Inflammation and Dysfunction

Refractive Surgery Review

When refractive surgery doesn’t go to plan: a definitive guide to managing complications

  • January 20, 2026

  • 3 min